Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer and is characterized as estrogen and progesterone receptor-negative and human epidermal growth factor receptor 2 (HER2) negative. This evidence concerns the gene ERBB2 and breast carcinoma.